Gofen & Glossberg LLC IL Increases Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Gofen & Glossberg LLC IL increased its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating) by 0.5% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 89,393 shares of the pharmacy operator’s stock after purchasing an additional 476 shares during the period. Gofen & Glossberg LLC IL’s holdings in Walgreens Boots Alliance were worth $3,388,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. BlackRock Inc. lifted its holdings in shares of Walgreens Boots Alliance by 4.9% in the 1st quarter. BlackRock Inc. now owns 57,751,600 shares of the pharmacy operator’s stock valued at $2,585,537,000 after buying an additional 2,719,081 shares during the period. State Street Corp lifted its holdings in shares of Walgreens Boots Alliance by 6.2% in the 1st quarter. State Street Corp now owns 49,822,222 shares of the pharmacy operator’s stock valued at $2,230,541,000 after buying an additional 2,911,384 shares during the period. Capital World Investors lifted its holdings in shares of Walgreens Boots Alliance by 7.3% in the 4th quarter. Capital World Investors now owns 21,522,395 shares of the pharmacy operator’s stock valued at $1,122,608,000 after buying an additional 1,462,083 shares during the period. Invesco Ltd. increased its stake in shares of Walgreens Boots Alliance by 7.1% in the 1st quarter. Invesco Ltd. now owns 9,124,025 shares of the pharmacy operator’s stock valued at $408,481,000 after purchasing an additional 601,844 shares in the last quarter. Finally, Bank of New York Mellon Corp increased its stake in shares of Walgreens Boots Alliance by 4.7% in the 1st quarter. Bank of New York Mellon Corp now owns 7,170,451 shares of the pharmacy operator’s stock valued at $321,022,000 after purchasing an additional 323,397 shares in the last quarter. 57.33% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

WBA has been the subject of several recent analyst reports. Credit Suisse Group cut their price target on Walgreens Boots Alliance from $52.00 to $43.00 and set a “neutral” rating for the company in a research note on Friday, July 1st. JPMorgan Chase & Co. cut their price objective on Walgreens Boots Alliance from $52.00 to $45.00 and set a “neutral” rating for the company in a research note on Friday, July 8th. Barclays dropped their price target on Walgreens Boots Alliance from $50.00 to $45.00 and set an “equal weight” rating for the company in a research report on Friday, June 24th. Morgan Stanley dropped their price target on Walgreens Boots Alliance from $43.00 to $39.00 and set an “underweight” rating for the company in a research report on Wednesday, July 6th. Finally, StockNews.com upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating in a research report on Friday, August 19th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $45.75.

Walgreens Boots Alliance Stock Performance

NASDAQ:WBA opened at $33.32 on Friday. The business’s fifty day moving average price is $37.44 and its 200 day moving average price is $41.31. The firm has a market capitalization of $28.80 billion, a PE ratio of 5.37, a price-to-earnings-growth ratio of 1.44 and a beta of 0.62. Walgreens Boots Alliance, Inc. has a 12 month low of $32.92 and a 12 month high of $55.00. The company has a debt-to-equity ratio of 0.35, a current ratio of 0.78 and a quick ratio of 0.43.

Walgreens Boots Alliance (NASDAQ:WBAGet Rating) last announced its earnings results on Thursday, June 30th. The pharmacy operator reported $0.96 earnings per share for the quarter, topping the consensus estimate of $0.95 by $0.01. The business had revenue of $32.60 billion during the quarter, compared to the consensus estimate of $32.23 billion. Walgreens Boots Alliance had a net margin of 4.00% and a return on equity of 16.20%. The business’s quarterly revenue was down 4.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.51 earnings per share. On average, sell-side analysts anticipate that Walgreens Boots Alliance, Inc. will post 5.02 earnings per share for the current fiscal year.

Walgreens Boots Alliance Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, September 9th. Shareholders of record on Friday, August 19th were paid a $0.48 dividend. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.48. This represents a $1.92 annualized dividend and a yield of 5.76%. The ex-dividend date of this dividend was Thursday, August 18th. Walgreens Boots Alliance’s payout ratio is presently 30.97%.

Walgreens Boots Alliance Profile

(Get Rating)

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

Recommended Stories

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.